Abstract
Of 139 node-positive breast cancer patients treated with adjuvant chemotherapy, the pre-treatment levels of glutathione S-transferase (GST) classes alpha, mu and pi, were determined by immuno-quantification on Western blots in cytosols of the primary tumours. Their expression was studied with respect to cytosolic oestrogen-receptor, progesterone-receptor and cathepsin D levels, and to the length of disease-free survival. GST class pi was negatively correlated with oestrogen receptor and progesterone receptor, and positively correlated with cathepsin D. There was no correlation between GST isoenzymes and the length of disease-free survival. These data suggest that glutathione S-transferases are not useful as markers to predict the response to adjuvant chemotherapy in human breast cancer.
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Peters, W., Roelofs, H., van Putten, W. et al. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer 68, 86–92 (1993). https://doi.org/10.1038/bjc.1993.291
Issue Date:
Further reading
-
Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2α Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
American Journal of Clinical Oncology (2013)
-
GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer
Cancer Science (2012)
-
Glutathione-S-Transferase-Pi Expression in Early Breast Cancer: Association With Outcome and Response to Chemotherapy
Cancer Investigation (2010)
-
Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue
Breast Cancer Research and Treatment (2008)
-
Association of GSTP1 CpG Islands Hypermethylation with Poor Prognosis in Human Breast Cancers
Breast Cancer Research and Treatment (2006)